Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Risperidone vs. Bupropion ER Augmentation of SSRIs in Treatment-Resistant Depression
This study has been completed.
Study NCT00179244 Information provided by Vanderbilt University
First Received: September 13, 2005 Last Updated: January 31, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Unipolar Depression
Additional conditions recognized in this trial
Depression
Depressive Disorder
More general conditions related to this trial
Behavioral Symptoms
Mental Disorders
Mood Disorders
Additional drug interventions recognized in this trial
Bupropion
Risperidone
More general drug interventions related to this trial
Antidepressive Agents
Antidepressive Agents, Second-Generation
Antipsychotic Agents
Central Nervous System Agents
Central Nervous System Depressants
Dopamine Agents
Dopamine Antagonists
Dopamine Uptake Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Antagonists
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Vanderbilt University
Janssen Pharmaceutica N.V., Belgium
Back to top of Main Content
